Targeted drug combo tested for Tough-to-Treat cancers
Disease control
Terminated
This study tested a drug called zenocutuzumab, combined with other cancer medications, for people with two specific advanced cancers. It aimed to see if the combinations could help control tumors in patients with a certain genetic change (NRG1+) in their lung cancer or in men who…
Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC